Protalix BioTherapeutics (AMEX:PLX) reported its Q4 earnings results on Thursday, March 31, 2022 at 06:50 AM.
Here's what investors need to know about the announcement.
Earnings
Protalix BioTherapeutics missed estimated earnings by 27.27%, reporting an EPS of $-0.14 versus an estimate of $-0.11.
Revenue was down $10.95 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 4.35% drop in the share price the next day.
Here's a look at Protalix BioTherapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.08 | -0.17 | -0.08 |
| EPS Actual | -0.09 | -0.25 | -0.14 | 0.03 |
| Revenue Estimate | 7.79M | 8.30M | 10.95M | 11.99M |
| Revenue Actual | 12.05M | 6.43M | 11.32M | 19.50M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
